Article
FOXP3+ T regulatory lymphocytes in primary melanoma are associated with BRAF mutation but not with response to BRAF inhibitor.
Pathology - 1 Oct 2015
Leslie Connull, Bowyer Samantha E, White Alison, Grieu-Iacopetta Fabienne, Trevenen Michelle, Iacopetta Barry, Amanuel Benhur, Millward Michael
Abstract excerpt
Tumour infiltrating lymphocytes in primary melanoma have been found to correlate with patient outcomes. A subpopulation of tumour infiltrating lymphocytes expresses the transcription factor forkhead box protein 3 (FOXP3). These are known as FOXP3+ T-regulatory cells (Tregs) and are thought to play an immune suppressive role in tumourigenesis. In most tumours, including melanoma, a high density of intratumoural...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
